Profile

Cover photo
Verified name
Sally Church
Works at Icarus Consultants
5,160 followers|66,682 views
AboutPostsPhotosYouTube

Stream

Sally Church

Shared publicly  - 
 
What's hot in breast cancer? Why, immunotherapy is!
The Checkpoints Show. Checkpoint inhibitors targeting PD1 PDL1 pathway show promise in triple negative breast cancer
1
1
Suzan St Maur's profile photo
Add a comment...

Sally Church

Shared publicly  - 
 
European Lung Cancer Conference 2015 AZD9291 EGFR Inhibitor showed longer PFS in NSCLC patients with a T790M mutation
1
Add a comment...

Sally Church

commented on a video on YouTube.
Shared publicly  - 
 
I do something similar in my A6 planner - appts on left, to-dos on right separated by a thin blue line and nots on the bottom. Still looking for the perfect pens, tend to use my Kaweco Sport fountain pens or a Unistylefit. I avoid the pilot hi-tecs as they are very scratchy 
1
Add a comment...

Sally Church

Shared publicly  - 
 
Potential of EBV-CTL T-Cell Therapy for Epstein-Barr Virus Lymphoproliferative Disorders
1
Sushil Sharma's profile photo
 
Job in Pharmacist
Add a comment...

Sally Church

Shared publicly  - 
 
The trials in this market are on the move again...
Dr Krishna Komanduri discusses CAR-T Cell Therapy GVHD and Gene Therapy abstracts at BMT Tandem meeting in San Diego
1
Add a comment...

Sally Church

Shared publicly  - 
 
This work could have a huge implication for future clinical trial design in colon cancer...
Precision medicine approaches may be possible in colorectal cancer if we can identify new subsets and treat with targeted therapies
1
Add a comment...
Have them in circles
5,160 people
Sue Searle's profile photo
Adrian O'Connor's profile photo
Emir Şevkioğlu's profile photo
Fitriya Zulaikha's profile photo
Jewel Crux's profile photo
Steven Healey's profile photo
Amilcar Aristides Monteiro's profile photo
Elliot Savett's profile photo
paolo “RICETTEDASBALLO” orlando's profile photo

Sally Church

Shared publicly  - 
 
Some interesting new data for combinations with AZD9291 in T790M lung cancer and new data for Ariad's brigatinib in ALK-positive tumours
2nd and 3rd generation ALK inhibitors look increasingly promising in crizotinib refractory patients as does targeting c-MET in combination with T790M inhibitors
1
Add a comment...

Sally Church

Shared publicly  - 
 
A promising new cancer immunotherapy target...
STING is a central mediator of innate immune response that stimulates cytokine production boosting T cells
1
Add a comment...

Sally Church

Shared publicly  - 
 
Novel targets in urothelial bladder cancer may offer options for new antibody and CAR-T cell therapy development
1
Add a comment...

Sally Church

Shared publicly  - 
 
Some new exciting combination approaches are likely to emerge soon...
Early data from ASH 2014 suggests that monotherapy with checkpoint inhibitors will not be sufficient so where do we go next?
1
Add a comment...

Sally Church

Shared publicly  - 
 
I think we will start seeing more combination approaches emerge that will shift outcomes for cancer patients...
Improved survival was seen in advanced prostate cancer when Prostvac was combined with ipilimumab
1
Add a comment...

Sally Church

Shared publicly  - 
 
Which new combinations could improve outcomes for colon cancer patients receiving EGFR therapies?
1
Add a comment...
People
Have them in circles
5,160 people
Sue Searle's profile photo
Adrian O'Connor's profile photo
Emir Şevkioğlu's profile photo
Fitriya Zulaikha's profile photo
Jewel Crux's profile photo
Steven Healey's profile photo
Amilcar Aristides Monteiro's profile photo
Elliot Savett's profile photo
paolo “RICETTEDASBALLO” orlando's profile photo
Work
Occupation
Management Consultant
Employment
  • Icarus Consultants
    Management Consultant, present
  • Novartis
  • Sandoz UK
Story
Introduction
Who am I?
I'm a marketer, a scientist, a maverick, a consultant and a problem solver.

What do I do?
People come to me with their problems and we find creative solutions.  I'm a science and data geek we make data sing.

What sort of problems? 
Strategic marketing, competitive intelligence, landscape opportunity assessments, KOL market research, social media monitoring.  Find out more detail here

What sort of clients? 
Pharma and biotechnology companies. 
We specialise in oncology and hematology, but have also completed projects in immunology, diabetes, respiratory, CNS and many others.

How can you find or contact me?
Via my blog